Document is current
Any future updates will be listed below
-
Authors
Strizova, Zuzana https://orcid.org/0000-0003-4976-9534
Snajdauf, Martin
Stakheev, Dmitry
Taborska, Pavla
Vachtenheim, Jiri Jr
Biskup, Jan
Lischke, Robert
Bartunkova, Jirina
Smrz, Daniel https://orcid.org/0000-0003-0143-8744
-
Funding
Funding for this research was provided by:
Univerzita Karlova v Praze (GA UK No. 364218)
Univerzita Karlova v Praze (PRIMUS/MED/12)
Ministerstvo Zdravotnictví Ceské Republiky (AZV 16-28135A)
- License Information
-
More Information
Article History
Received: 25 January 2020
Accepted: 12 May 2020
First Online: 23 May 2020
Compliance with ethical standards
:
: J. Bartunkova is a part-time employee and a minority shareholder of Sotio, a.s., a biotech company developing cell-based immunotherapy. Z. Strizova, M. Snajdauf, D. Stakheev, P. Taborska, J. Vachtenheim Jr, J. Biskup, R. Lischke, and D. Smrz declare no conflict of interest.
: This study was approved by the Ethics committee for multicentric studies and evaluation of the Faculty Hospital Motol, Prague, Czech Republic. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
